Intellia Therapeutics Announces Fourth Quarter and Full-Year 2021 Financial Results and Highlights Recent Company Progress

Go back to Intellia Therapeutics Announces Fourth Quarter and Full-Year 2021 Financial Results and Highlights Recent Company Progress
(NASDAQ: NTLA) Delayed: 15.11 -0.64 (4.06%)
Previous Close $15.75    52 Week High $30.40 
Open $15.43    52 Week Low $11.86 
Day High $15.93    P/E N/A 
Day Low $15.10    EPS $0.00 
Volume 1,895,036